The FDA has issued a critical warning regarding tianeptine products, citing serious health risks such as seizures, loss of consciousness, and death. Neptune Resources, LLC, manufacturer of Neptune’s Fix, has voluntarily recalled all batches of their tianeptine products. With concerns over tianeptine’s potential to mimic opioid toxicity and interact dangerously with other medications, the FDA urges consumers and retailers to dispose of or return these products immediately. The agency has also appealed to retail outlets to cease the sale of all tianeptine-containing products, emphasizing public safety as a top priority.
Home » FDA Issues Recall and Warning on Tianeptine Products
FDA Issues Recall and Warning on Tianeptine Products
Facebook
Twitter
LinkedIn
Email
WhatsApp
Facebook
Twitter
LinkedIn
Email
WhatsApp
Related Shorts
Fasting Mimetic Supplement Shows Cardioprotective Promise
November 30, 2024
Breaking the Code: Enzyme TYK2 Offers Hope for Alzheimer’s Treatment
November 30, 2024
Sucrosomial® B12: A Breakthrough in B12 Supplementation
November 30, 2024
Harnessing Beneficial Bacteria: A Breakthrough in UTI Management
November 25, 2024
Activ’Inside’s Belight: A Natural Solution for Skin Hyperpigmentation
November 22, 2024